Farzaneh-Far Ramin
Insider CIK 1688195 · RARX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 73,654 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 11,110 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 90,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 62,500 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 133,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 10,416 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer | 2020-04-02 | 2020-04-03 | 14,492 | $48.00 | $695.6K | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-03-16 | 2020-03-18 | 9,206 | — | $0 | 73,654 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-03-16 | 2020-03-18 | 1,389 | — | $0 | 11,110 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2020-03-16 | 2020-03-18 | 10,595 | $45.16 | $478.5K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-03-16 | 2020-03-18 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-03-16 | 2020-03-18 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,389 | — | $0 | 12,499 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-02-18 | 2020-02-20 | 9,206 | — | $0 | 82,860 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2020-02-18 | 2020-02-20 | 10,595 | $46.61 | $493.8K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-02-18 | 2020-02-20 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-02-18 | 2020-02-20 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-01-15 | 2020-01-16 | 9,206 | — | $0 | 92,066 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2020-01-15 | 2020-01-16 | 1,389 | — | $0 | 13,888 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-01-15 | 2020-01-16 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2020-01-15 | 2020-01-16 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2020-01-15 | 2020-01-16 | 10,595 | $46.95 | $497.4K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 1,389 | — | $0 | 15,277 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 9,206 | — | $0 | 101,272 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-12-16 | 2019-12-18 | 10,595 | $47.23 | $500.4K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-11-15 | 2019-11-18 | 9,206 | — | $0 | 110,478 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-11-15 | 2019-11-18 | 1,389 | — | $0 | 16,666 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-11-15 | 2019-11-18 | 10,595 | $46.66 | $494.4K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-11-15 | 2019-11-18 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-11-15 | 2019-11-18 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-10-15 | 2019-10-17 | 1,389 | — | $0 | 18,055 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-10-15 | 2019-10-17 | 9,206 | — | $0 | 119,684 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-10-15 | 2019-10-17 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-10-15 | 2019-10-17 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-10-15 | 2019-10-17 | 10,595 | $46.89 | $496.8K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-09-16 | 2019-09-16 | 9,206 | — | $0 | 128,890 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-09-16 | 2019-09-16 | 1,389 | — | $0 | 19,444 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-09-16 | 2019-09-16 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-09-16 | 2019-09-16 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-09-16 | 2019-09-16 | 10,595 | $25.26 | $267.6K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-08-23 | 2019-08-27 | 1,389 | — | $0 | 20,833 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-08-23 | 2019-08-27 | 9,206 | — | $0 | 138,096 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-08-23 | 2019-08-27 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-08-23 | 2019-08-27 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-08-23 | 2019-08-27 | 10,595 | $27.77 | $294.2K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-07-15 | 2019-07-16 | 1,389 | — | $0 | 22,222 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-07-15 | 2019-07-16 | 9,206 | — | $0 | 147,302 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-07-15 | 2019-07-16 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-07-15 | 2019-07-16 | 6,379 | $32.97 | $210.3K | 11,348 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-07-15 | 2019-07-16 | 4,216 | $33.29 | $140.4K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-07-15 | 2019-07-16 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-06-17 | 2019-06-19 | 9,206 | — | $0 | 156,508 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-06-17 | 2019-06-19 | 1,389 | — | $0 | 23,611 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-06-17 | 2019-06-19 | 9,206 | $5.60 | $51.6K | 17,727 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-06-17 | 2019-06-19 | 3,411 | $21.41 | $73.0K | 14,316 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | S Sale | 2019-06-17 | 2019-06-19 | 7,184 | $22.04 | $158.3K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-06-17 | 2019-06-19 | 1,389 | $5.60 | $7.8K | 8,521 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 133,000 | — | $0 | 133,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 10,417 | — | $0 | 20,833 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 3,285 | $21.00 | $69.0K | 7,132 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 10,417 | — | $0 | 10,417 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 62,500 | — | $0 | 62,500 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 31,250 | — | $0 | 31,250 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2017-02-01 | 2017-02-03 | 90,000 | — | $0 | 90,000 | SEC↗ |